RxDoctor Payments Data

Joseph Hoffman

Pulmonary Disease · Park Ridge, NJNPI 1619103629

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,110,962 of the $1,113,615 with a category attached, or 99.8%. 3 manufacturers reported payments, led by Exelixis Inc. at 39.9% of the total. Reporting peaked in 2020 at $383,278 and has fallen 91.9% since, to $31,012 in 2024. Among pulmonary disease clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,113,615in general payments, 2019–2025

Across 80 payments — averaging $13,920 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exelixis Inc.$444K
  • Mallinckrodt Hospital Products Inc.$351K
  • Regeneron$319K

What the payments were for

  • Consulting fees$1,110,962100%
  • Travel & lodging$2,6370%
  • Food & beverage$160%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Exelixis Inc.40$444,250
Mallinckrodt Hospital Products Inc.17$350,653
Regeneron23$318,712

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,113,615 in reported general payments places this provider in the 95th percentile of 472 pulmonary disease providers in New Jersey.

See all pulmonary disease providers in New Jersey

Other pulmonary disease in Park Ridge

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →